Acrivon Therapeutics, Inc. Common StockACRVNASDAQ
LOADING
|||
Operating Income Growth Accelerating
Trending higher, above historical average.
Left:
||||
Year-over-year operating income growth rate
Latest
13.08%
↑ 184% above average
Average (16q)
-15.50%
Historical baseline
Range
High:17.85%
Low:-68.90%
Volatility
-559.7%
Relatively stable
| Period | Value |
|---|---|
| Q3 2025 | 13.08% |
| Q2 2025 | -4.56% |
| Q1 2025 | 13.19% |
| Q4 2024 | 0.74% |
| Q3 2024 | -17.27% |
| Q2 2024 | -21.33% |
| Q1 2024 | 16.08% |
| Q4 2023 | -30.46% |
| Q3 2023 | -3.98% |
| Q2 2023 | -7.83% |
| Q1 2023 | -44.73% |
| Q4 2022 | -3.86% |
| Q3 2022 | -61.60% |
| Q2 2022 | 17.85% |
| Q1 2022 | -68.90% |
| Q4 2021 | -59.87% |
| Q3 2021 | 0.00% |